Wei Li

Tepotinib plus gefitinib in patients with EGFR-mutant non-small-cell lung cancer with MET overexpression or MET amplification and acquired resistance to previous EGFR inhibitor (INSIGHT study): an open-label, phase 1b/2, multicentre, randomised trial

Yi‐Long Wu, Ying Cheng, Jianying Zhou et al. · The Lancet Respiratory Medicine · 2020 · 258 citations

Medicine, Oncology, Pharmacology +17

Circular RNA circ‐TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA

Xiaojuan Pan, Bo Huang, Qiang Ma et al. · Clinical and Translational Medicine · 2022 · 101 citations · Full text

Medicine, Molecular Biology, Oncology +17

TIGAR Has a Dual Role in Cancer Cell Survival through Regulating Apoptosis and Autophagy

Jiaming Xie, Bin Li, Hong-Pei Yu et al. · Cancer Research · 2014 · 84 citations

Life Sciences, Oncology, Pharmacology +17

Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis

Wenbin Liu, Wei Li, Haidan Liu et al. · International Journal of Biological Sciences · 2019 · 83 citations · Full text

Medicine, Oncology, Pharmacology +17

Acute arsenic exposure induces inflammatory responses and CD4+ T cell subpopulations differentiation in spleen and thymus with the involvement of MAPK, NF-kB, and Nrf2

Xiaoxu Duan, Shuang Gao, Jin‐Long Li et al. · Molecular Immunology · 2016 · 82 citations

Veterinary Medicine, Immunology, Toxicology +12